Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

HCA Healthcare (NYSE: HCA) Busy Session: What the Latest Filings Show on Third Quarter Revenues of $19.849 Billion and 2026 Guidance

HCA Healthcare, Inc. (NYSE: HCA) shares were trading at USD 442.78 on October 27, 2026, down 4.83%, with a relative volume at time of 4.29. The hospital operator reported third quarter 2026 results on October 27, including revenues of $19.849 billion, a quarterly dividend …

Nitish Kishor | 27 October 2026

IQVIA (NYSE: IQV) Sees Unusual Volume: What the Latest Filings Show on Third-Quarter 2026 Revenue, Backlog and Raised Guidance

IQVIA Holdings Inc. (NYSE: IQV) shares were trading at USD 270.99 on October 27, 2026, down 0.95%, with a relative volume at time of 3.14. The healthcare data and clinical research company reported third-quarter 2026 results on October 27, 2026, raised its full-year 2026 …

Nitish Kishor | 27 October 2026

Kiniksa Pharmaceuticals (NASDAQ: KNSA) Active Trading Today: Third Quarter ARCALYST Net Product Revenue of $286.0 Million

Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA) shares were trading at USD 89.48 on October 27, 2026, up 22.61%, with a relative volume at time of 3.49. The biopharmaceutical company reported third quarter 2026 results on October 27, 2026, raised its 2026 ARCALYST net product …

Nitish Kishor | 27 October 2026

A Closer Look at Mineralys Therapeutics (NASDAQ: MLYS): Busy Session, Second Quarter Net Loss of $241.1 Million and December 22 PDUFA Date in Focus

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) shares were trading at USD 20.74 on October 27, 2026, up 0.88%, with a relative volume at time of 4.69. The clinical-stage company filed its 10-Q for the quarter ended June 30, 2026 on August 11, entered a term …

Nitish Kishor | 27 October 2026

A Closer Look at NeoGenomics (NASDAQ: NEO): Volume Stands at 3.24 Relative, CEO Succession and Preliminary Third Quarter Revenue in Focus

NeoGenomics, Inc. (NASDAQ: NEO) shares were trading at USD 17.25 on October 27, 2026, up 3.36%, with a relative volume at time of 3.24. On October 5, 2026 the oncology diagnostics company announced an executive and board succession plan, along with preliminary unaudited third …

Nitish Kishor | 27 October 2026

A Closer Look at ORIC Pharmaceuticals (NASDAQ: ORIC): Busy Session, Second Quarter Net Loss and Himalayas-1 Phase 3 Trial in Focus

ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) shares were trading at USD 9.02 on October 27, 2026, up 0.75%, with a relative volume at time of 2.98. The clinical-stage oncology company entered a clinical trial collaboration and supply agreement with Bayer on July 7, 2026, for …

Nitish Kishor | 27 October 2026

In Play Today, RadNet (NASDAQ: RDNT) Reports Second Quarter 2026 Service Revenue of $622,720 Thousand

RadNet, Inc. (NASDAQ: RDNT) shares were trading at USD 73.43 on October 27, 2026, up 4.83%, with a relative volume at time of 7.67. The diagnostic imaging and digital health company acquired Gleamer SAS in the first quarter of 2026, entered a $250.0 million …

Nitish Kishor | 27 October 2026

Tenet Healthcare (NYSE: THC) Volume Spotlight: What the Latest Filings Show on Second Quarter Income, Contract Termination Revenue and 2026 Guidance

Tenet Healthcare Corporation (NYSE: THC) shares were trading at USD 259.51 on October 27, 2026, down 3.51%, with a relative volume at time of 4.18. The hospital and ambulatory care operator filed its Form 10-Q for the quarter ended June 30, 2026 on July …

Nitish Kishor | 27 October 2026

Universal Health Services (NYSE: UHS) Volume Stands at 4.82 Relative: What the Latest Filings Show on Second Quarter Revenues and the Talkspace Agreement

Universal Health Services, Inc. (NYSE: UHS) shares were trading at USD 174.23 on October 27, 2026, down 6.18%, with a relative volume at time of 4.82. The hospital operator agreed to acquire Talkspace on March 9, 2026, acquired Irish residential facilities in July 2026, …

Nitish Kishor | 27 October 2026

What Absci (NASDAQ:ABSI) Investors Should Know as Shares Climb 12% on ABS-201 Half-Life Data

Absci (NASDAQ:ABSI) shares are trading up 11.64% to $10.55 as investors stay focused on the ABS-201 hair-loss program after positive interim Phase 1 data. The data showed an estimated antibody half-life of at least 65 days. Shares opened at $9.45, and the 52-week range …

Nitish Kishor | 27 October 2026
Support

Hi! How can we help you today?

Loading…